Health Care: Drugs

IDEXX Laboratories Inc (IDXX: NASDAQ)

$164.65 2.21 | 1.36%
06/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 1.78B 1.60B 1.49B 1.38B
Cost of Sales 720.93M 641.23M 610.80M 566.34M
Gross Operating Profit 1.05B 960.66M 875.00M 810.71M
Selling, General, and Administrative Expenses 524.08M 482.46M 457.60M 401.35M
Research & Development 101.12M 99.68M 98.26M 88.00M
Operating Income before D & A (EBITDA) 429.30M 378.51M 319.14M 321.36M
Depreciation & Amortization 79.06M 70.39M 58.89M 54.60M
Interest Income 3.66M 2.47M 1.73M 1.89M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 -8.21M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 353.89M 302.38M 261.98M 268.65M
Interest Expense 32.05M 29.24M 15.43M 5.39M
Pre-Tax Income 321.85M 273.14M 246.56M 263.26M
Income Taxes 99.79M 81.01M 64.60M 75.47M
Minority Interest 9.00K 57.00K 45.00K -6.00K
Net Income From Continuing Operations 222.05M 192.13M 181.95M 187.79M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 222.05M 192.13M 181.95M 187.79M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 222.04M 192.08M 181.91M 187.80M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
222.05M 200.35M 181.95M 187.79M
Preferred Dividends
Net Income Available To Common 222.05M 192.13M 181.95M 187.79M
Basic EPS from Continuing Ops. 2.47 2.07 1.82 1.77
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.47 2.07 1.82 1.77
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.47 2.07 1.82 1.77
Basic Normalized Net Income/Share 2.47 2.16 1.82 1.77
EPS fr Continuing Ops. 2.44 2.05 1.79 1.74
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.44 2.05 1.79 1.74
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.44 2.05 1.79 1.74
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.44 2.14 1.79 1.74
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDXX

Latest IDXX Headlines from TheStreet

More Financial News for IDXX

Press Releases for IDXX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter